Yiaco Medical serves 18 countries and represents 80 healthcare companies in the Middle East and North Africa with a population of more than 400 million.
Hamed Hamadah, chairman and managing director, Yiaco Medical, said: “Through this collaboration with Pro-Pharmaceuticals, we have now gained access to a promising cancer therapy that potentially allows us to address an area of high medical importance where current therapies are clearly inadequate.”